RICHARD EDWIN JONES MD NPI 1174507800

NPI Details

Richard Edwin Jones, MD is a rheumatology internal medicine in Northport, AL with 32 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Richard Edwin Jones, MD NPI is 1174507800. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:1994

The provider's business location address is:

4280 WATERMELON RD STE 112
NORTHPORT, AL
ZIP 35473-250
Phone: (205) 750-0030
Fax: (205) 750-0855

The NPI 1174507800 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Vitamin d-3 level (HCPCS:82306)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• X-ray of wrist, 2 views (HCPCS:73100)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Complete ultrasound scan of joint (HCPCS:76881)
• X-ray of foot, 2 views (HCPCS:73620)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Tuberculosis test, enumeration of t-cells (HCPCS:86481)
• X-ray of ankle, 2 views (HCPCS:73600)
• X-ray of chest, 2 views (HCPCS:71046)
• Uric acid level, blood (HCPCS:84550)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
• Automated urinalysis test (HCPCS:81003)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• X-ray of knee, 3 views (HCPCS:73562)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Application of hot wax bath (HCPCS:97018)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Measurement of dna antibody, single stranded (HCPCS:86226)
• Rheumatoid factor level (HCPCS:86431)
• X-ray of upper spine, 2-3 views (HCPCS:72040)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• X-ray of middle spine, 2 views (HCPCS:72070)
• X-ray of hip, 2-3 views (HCPCS:73502)
• X-ray of both hips, 2 views (HCPCS:73521)
• X-ray of joint between lower spine and hip bone, 1-2 views (HCPCS:72200)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)

The enumeration date for this NPI number is 12/6/2005 and was last updated on 1/20/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.